All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Source-checked decision dossier

How to Verify a Compounding Pharmacy: A Reproducible Checklist

Verify identity, state licensure, federal registration claims, inspections, recalls, and product-specific documentation.

Verified 2026-08-253 claim-level citationsMethodology

Bottom line

How can a patient verify a 503A pharmacy or 503B outsourcing facility before filling a prescription?

Verification is a chain, not a badge. Confirm the exact legal facility name and address, check the relevant state pharmacy license, confirm any claimed 503B registration on FDA’s current list, review inspection and recall records, and ask for product-specific documentation. FDA registration alone is not approval of the compounded drug or proof that the facility is currently compliant.

Primary-source comparison

Every row links to the provider or regulator used. “Verify” means the public source did not establish that field clearly enough to score it.

OptionIdentityState licenseFederal statusInspection historyProduct documentation
503A verification pathExact pharmacy legal name and addressRequired; check state boardNot listed as a 503B solely because it is 503AFDA actions page + state boardRequest from pharmacy/provider
503B verification pathExact facility legal name and addressMay vary; 503B is a federal categoryCheck current FDA registration listReview 483, recall, and action fieldsRequest lot-specific documentation

Claims and evidence

Each claim carries its own scope, verification date, and source—not a generic bibliography at the bottom of the page.

FDA 503B registration does not mean a compounded drug is FDA-approved or that the facility has been found compliant with all requirements.
Scope: FDA’s own explanation of outsourcing-facility registration.
Source verifiedVerified 2026-08-251 source
  1. U.S. Food and Drug Administration: Questions and Answers: Outsourcing Facility Registration Accessed 2026-08-25.
FDA’s outsourcing-facility list includes registration, inspection, Form 483, recall, and action fields and is updated regularly.
Scope: The list is for 503B outsourcing facilities, not a complete directory of 503A state-licensed pharmacies.
Source verifiedVerified 2026-08-251 source
  1. U.S. Food and Drug Administration: Registered Outsourcing Facilities Accessed 2026-08-25.
FDA maintains a separate public index of compounding inspections, recalls, warning letters, and other actions.
Scope: Use it alongside state-board records and the current facility identity.
Source verifiedVerified 2026-08-251 source
  1. U.S. Food and Drug Administration: Compounding: Inspections, Recalls, and Other Actions Accessed 2026-08-25.

Reproducible methodology

How this page was built

  1. 1.Use provider, manufacturer, and regulator pages as primary sources; do not score claims copied from review sites.
  2. 2.Record the exact access date and distinguish starting prices, ongoing prices, membership fees, medication fees, and dose-dependent pricing.
  3. 3.Treat any field that cannot be reproduced from a primary source as not verified instead of estimating it.
  4. 4.Recheck volatile price and availability claims at least monthly and retain a public change log.

Verification

Last checked 2026-08-25. This page uses 3 disclosed sources and preserves unresolved fields as “not verified.”

Commercial disclosure

FormBlends sells telehealth programs and may benefit when a reader chooses FormBlends. Competitors are evaluated from their own published materials. Payment or affiliate relationships do not affect inclusion or source status.

Next decision

Use the evidence, then choose your path.

Review prescription options